SCHEMBL21614696

SCHEMBL21614696

CC(C)Oc1ccc(-c2ncc(CNc3cc(Cl)nc(Cl)c3)s2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 3/20 0.54
▸ KCNH2 Q12809 1/20 0.54
▸ CYP2C9 P11712 2/20 0.52
▸ HDAC3 O15379 5/20 0.39
▸ HDAC1 Q13547 5/20 0.39
▸ HDAC6 Q9UBN7 4/20 0.39
▸ MAP4K4 O95819 1/20 0.37
▸ S1PR1 P21453 1/20 0.36
▸ SYK P43405 1/20 0.35
▸ TRPV1 Q8NER1 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ ITGB3 P05106 1/20 0.34
▸ ITGB1 P05556 1/20 0.34
▸ ITGAV P06756 1/20 0.34
▸ ITGA2B P08514 1/20 0.34
▸ ITGA5 P08648 1/20 0.34
▸ ITGB5 P18084 1/20 0.34
▸ TP53 P04637 3/20 0.33
▸ POLB P06746 1/20 0.33
▸ P2RX3 P56373 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21612040 0.90 CYP2C19 (0.61) CYP2C19KCNH2CYP2C9HDAC3HDAC1
SCHEMBL21614697 0.78 CYP2C19 (0.55) CYP2C19KCNH2CYP2C9HDAC3HDAC1
SCHEMBL23627693 0.78 CYP2C19 (0.43) CYP2C19KCNH2CYP2C9HDAC3HDAC1
SCHEMBL21614772 0.78 CYP2C19 (0.75) CYP2C19KCNH2CYP2C9HDAC3HDAC1
SCHEMBL21612041 0.78 CYP2C19 (0.79) CYP2C19KCNH2CYP2C9S1PR1
SCHEMBL30062377 0.76 CYP2C19 (0.51) CYP2C19KCNH2CYP2C9CYP3A4TP53
SCHEMBL23611234 0.76 CYP2C19 (0.51) CYP2C19KCNH2CYP2C9CYP3A4TP53
SCHEMBL31694534 0.76 CYP2C19 (0.53) CYP2C19KCNH2CYP2C9HDAC3HDAC1
SCHEMBL31694535 0.76 CYP2C19 (0.50) CYP2C19KCNH2CYP2C9HDAC3HDAC1
SCHEMBL23611317 0.76 CYP2C19 (0.52) CYP2C19KCNH2CYP2C9HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210353606-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2021-11-18 — — US disclosed
WO-2020007938-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2020-01-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210353606-A1 PqsR INVERSE AGONISTS QRFPR, P2RY11, QARS1 CYP2C19 1824/4885KCNH2 2343/4885CYP2C9 2997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback